Related Experiment Video
Updated: Sep 6, 2025

Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Published on: May 15, 2014
Prevention and Treatment of Monkeypox
John G Rizk1, Giuseppe Lippi2, Brandon M Henry3
1Department of Pharmaceutical Health Services Research, University of Maryland, Baltimore, School of Pharmacy, 220 Arch Street, 12th Floor, Room 01-409-E, Baltimore, MD, 21201, USA. john.rizk@umaryland.edu.
Medical countermeasures for human monkeypox, a zoonotic orthopoxvirus, include two vaccines and available treatments like antivirals and vaccinia immune globulin intravenous (VIGIV) for severe cases.
Area of Science:
- Virology
- Public Health
Background:
- Human monkeypox is a zoonotic orthopoxvirus presenting similarly to smallpox.
- Transmission occurs through animal contact, direct human contact (skin-to-skin, sexual), respiratory droplets, and fomites.
Purpose of the Study:
- To review available medical countermeasures for human monkeypox.
- To describe the applications of vaccines, antivirals, and vaccinia immune globulin intravenous (VIGIV).
Main Methods:
- Literature review of medical countermeasures for orthopoxviruses.
- Summary of available vaccines: JYNNEOS™ and ACAM2000®.
- Overview of antiviral treatments (tecovirimat, brincidofovir, cidofovir) and VIGIV.
Main Results:
- Two vaccines, JYNNEOS™ and ACAM2000®, are stockpiled for orthopoxviruses.
- Antivirals and VIGIV are available for severe monkeypox cases, immunocompromised individuals, and specific patient groups.
- Supportive care is sufficient for most mild, self-limited monkeypox cases.
Conclusions:
- A range of medical countermeasures exist for human monkeypox.
- Vaccines, antivirals, and VIGIV provide options for prevention and treatment.
- Targeted use of antivirals is recommended for severe or complicated monkeypox cases.
More Related Videos
Related Concept Videos
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Cross-reactivity
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...

